Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis chief Jimenez touts two top PhIII drug prospects
Novartis chief Jimenez touts two top PhIII drug prospects
Novartis chief Jimenez touts two top PhIII drug prospects
Submitted by
admin
on January 18, 2017 - 10:07am
Source:
Endpoints
News Tags:
Novartis
Joe Jimenez
CTL-019
BAF-312
CAR-T
progressive MS
multiple sclerosis
Headline:
Novartis chief Jimenez touts two top PhIII drug prospects
Do Not Allow Advertisers to Use My Personal information
